AI Verdict
JBI has stronger fundamentals based on our AI analysis.
JBI vs JAZZ Fundamental Comparison
| Metric | JBI | JAZZ |
|---|---|---|
| Revenue | $884.2M | $4.3B |
| Net Income | $53.8M | $-356.1M |
| Net Margin | 6.1% | -8.3% |
| ROE | 9.4% | -8.2% |
| ROA | 4.1% | -3.1% |
| Current Ratio | 3.54x | 1.86x |
| Debt/Equity | 0.94x | 1.24x |
| EPS | $0.38 | $-5.84 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
JBI vs JAZZ: Frequently Asked Questions
Is JBI or JAZZ a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), JBI has stronger fundamentals. JBI is rated HOLD (62% confidence) while JAZZ is rated SELL (78% confidence). This is not investment advice.
How does JBI compare to JAZZ fundamentally?
Janus International Group, Inc. has ROE of 9.4% vs Jazz Pharmaceuticals plc's -8.2%. Net margins are 6.1% vs -8.3% respectively.
Which stock pays higher dividends, JBI or JAZZ?
JBI has a dividend yield of N/A or no dividend while JAZZ has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in JBI or JAZZ for long term?
For long-term investing, consider that JBI has HOLD rating with 62% confidence, while JAZZ has SELL rating with 78% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about JBI vs JAZZ?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For JBI vs JAZZ, the AI consensus favors JBI based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.